80
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Elevating pancreatic cystic lesion stratification: Current and future pancreatic cancer biomarker(s)

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Pancreatic ductal adenocarcinoma (PDAC) is an incredibly deadly disease with a 5-year survival rate of 9%. The presence of pancreatic cystic lesions (PCLs) confers an increased likelihood of future pancreatic cancer in patients placing them in a high-risk category. Discerning concurrent malignancy and risk of future PCL progression to cancer must be carefully and accurately determined to improve survival outcomes and avoid unnecessary morbidity of pancreatic resection. Unfortunately, current image-based guidelines are inadequate to distinguish benign from malignant lesions. There continues to be a need for accurate molecular and imaging biomarker(s) capable of identifying malignant PCLs and predicting the malignant potential of PCLs to enable risk stratification and effective intervention management. This review provides an update on the current status of biomarkers from pancreatic cystic fluid, pancreatic juice, and seromic molecular analyses and discusses the potential of radiomics for differentiating PCLs harboring cancer from those that do not.

          Related collections

          Author and article information

          Journal
          Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
          Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
          Elsevier BV
          0304419X
          January 2020
          January 2020
          : 1873
          : 1
          : 188318
          Article
          10.1016/j.bbcan.2019.188318
          6980327
          31676330
          ffb354b5-55f7-46b0-87cf-99dec3a711b5
          © 2020

          https://www.elsevier.com/tdm/userlicense/1.0/

          History

          Comments

          Comment on this article